Moderna
MRNA
#74
Rank
$173.62 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ USA
Country
$430.14
Share price
-5.38%
Change (1 day)
519.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2021 (TTM): $2.73 B

According to Moderna 's latest financial reports the company's current revenue (TTM) is $2.73 B. In 2020 the company made a revenue of $0.80 B an increase over the years 2019 revenue that were of $0.06 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expences are substracted.

Revenue history for Moderna from 2018 to 2021

Year Revenue Change
2021 (TTM)$2.73 B240.06%
2020$0.80 B1234.34%
2019$0.06 B-55.42%
2018$0.13 B